UK private equity has made a slow start in the first quarter of 2016, following the highest number of buy-outs since 2007, according to figures published by the Centre for Management Buyout Research (CMBOR) at Imperial College Business School. The latest research, sponsored by Equistone Partners Europe Limited, shows that
The recovery rate for private equity transactions – the proportion of capital recovered in any deal where some loss has occurred – continues to maintain record levels of around 80 per cent, according to figures released by CEPRES. The results come from the new Loss & Recovery Benchmarking in PE.Analyzer,
An investment subsidiary of Investindustrial is to acquire Valtur Group from its current owners, Sofia which belongs to the Ljuljdjuraj family, who used to control the Valtur Group and will retain a minority shareholding. The acquisition of Valtur represents the first step of a global project aimed at creating a
Infosys, a specialist in consulting, technology and next-generation services, has partnered with Trifacta to provide a data wrangling solution for the Infosys Information Platform (IIP) and Infosys’ other platforms and offerings. Infosys clients can now leverage Trifacta’s intuitive self-service solution for exploring and transforming data—a critical step in any analytics
BlueVine, a leading online provider of everyday financing to small businesses, has secured a strategic investment from Citi Ventures. Financial terms of the investment have not been disclosed. Citi Ventures' investment will support BlueVine’s growth as it continues to scale its cloud-based working capital financing platform for small businesses and
PRA Group, a specialist in acquiring and collecting nonperforming loans, has completed its public tender offer to purchase shares of Warsaw-based DTP SA (DTP) on 26 April, 2016. Some 99.73 per cent of the shares in DTP have been tendered at PLN 4.90 per share (approximately USD1.26 per share), for
Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with ageing. Merz has joined a growing set of industry investors to back Boston-based Cytrellis Biosystems. The investment emphasizes Merz’ strategy to allocate
Venture capital firm Menlo Ventures has held the closing of the USD250 million Menlo Opportunity Fund, which will invest in early growth companies, typically Series B and C rounds, when the companies are at their initial inflection point. This is the first time Menlo Ventures has created a fund solely
European Buy & Build activity in 2015 reached its highest level since the first half of 2011, according to Silverfleet Capital’s annual European Buy & Build Monitor. The Buy & Build Monitor, which tracks global add-on activity undertaken by European headquartered companies backed by private equity, identified a provisional total
Mid-market private equity firm LDC has invested over GBP8 million in the management buyout of Vital Ingredient, a leading healthy food-to-go retailer, to support the roll-out of the group both within London and throughout the UK. Santander will provide a further GBP4 million of funding to support the expansion. Founder,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
